RegeneRx Biopharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. RegeneRx Biopharmaceuticals's past years’ income statements indicate that its last revenue has compared to the previous period by 0% to $76,761. The net income raised on -$1,727,272 and profit margin reached -2250%. Total operating expenses were $1,478,752.
Profit Margin
| 2013 | 29.48K | -671.34K | -2276.97% |
|---|---|---|---|
| 2014 | 0 | -2.75M | |
| 2015 | 60.61K | -5.27M | -8695.44% |
| 2016 | 93.30K | 229.12K | 245.56% |
| 2017 | 56.65K | 286.48K | 505.7% |
| 2018 | 69.66K | -1.99M | -2861.55% |
| 2019 | 76.76K | -1.55M | -2029.2% |
| 2020 | 76.76K | -1.75M | -2282.66% |
| 2021 | 76.76K | -1.92M | -2504.4% |
| 2022 | 76.76K | -1.72M | -2250.19% |
RGRX Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 76.76K | 76.76K | 76.76K | 76.76K | 69.66K | 56.65K | 93.30K | 60.61K | 0 | 29.48K |
Cost of revenue | 0 | 6 | 4 | 65 | 81 | 3.04K | 237 | 203 | 367 | 0 |
Gross profit | 76.76K | 76.75K | 76.75K | 76.69K | 69.58K | 53.60K | 93.07K | 60.40K | -367 | 29.48K |
Operating exp. | ||||||||||
Research and development | 0 | 6.63K | 4.92K | 65.10K | 81.04K | 143.91K | 237.34K | 203.18K | 367.27K | 188.64K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.47M | 1.40M | 1.37M | 1.33M | 1.39M | 1.50M | 1.76M | 1.77M | 1.55M | 943.73K |
Operating income | -1.40M | -1.32M | -1.29M | -1.26M | -1.32M | -1.44M | -1.67M | -1.70M | -1.55M | -914.25K |
Other income (expenses), net | -325.46K | -269.24K | -228.82K | -142.36K | -582.90K | 1.82M | 2.07M | -3.56M | -1.19M | 343.83K |
Income before tax | -1.72M | -1.59M | -1.52M | -1.40M | -1.99M | 385.09K | 229.12K | -5.27M | -2.75M | -671.34K |
Income tax expense | -183 | 324.64K | 228.82K | 153.41K | -582.90K | 98.60K | 173.35K | 172.88K | 183.47K | 100.94K |
Net income | -1.72M | -1.92M | -1.75M | -1.55M | -1.99M | 286.48K | 229.12K | -5.27M | -2.75M | -671.34K |
Earnings per share | ||||||||||
Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | -0.05 | -0.02 | -0.00 |
Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | -0.05 | -0.02 | -0.00 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |